Cannabis and Nausea

Not Medical Advice

This article is not medical advice. It summarizes published evidence for educational purposes. Nausea can be a symptom of serious conditions including bowel obstruction, pregnancy complications, infection, and neurological disease. If you are nauseated for more than a few days, vomiting blood, unable to keep fluids down, pregnant, or undergoing cancer treatment, talk to a clinician before self-medicating with cannabis or anything else. Cannabis interacts with many medications and is not legal everywhere.

Plain-Language Summary

Nausea is the feeling that you are about to vomit. Vomiting is the act itself. Both are controlled by a network in the brainstem (the area postrema and nucleus tractus solitarius) and the gut, and both respond to a wide variety of drugs that target serotonin, dopamine, histamine, and — relevantly here — the endocannabinoid system.

THC, the main intoxicating compound in cannabis, activates CB1 receptors in those brainstem regions and reliably reduces nausea and vomiting in many contexts Strong evidence ^[1][2]. This is why two synthetic/isolated THC drugs, dronabinol and nabilone, have been approved by the US FDA since the 1980s for chemotherapy-induced nausea and vomiting (CINV) that does not respond to standard drugs ^[3].

Whole-plant cannabis (smoked, vaporized, or eaten) is less well-studied than those isolated drugs, but observational and some randomized data suggest it also helps CINV Strong evidence ^[2][4]. Outside of chemotherapy, the evidence gets much weaker fast.

What Probably Works

Chemotherapy-induced nausea and vomiting (CINV). This is the single best-supported antiemetic use of cannabinoids. A 2015 JAMA systematic review of cannabinoids for medical use found moderate-quality evidence supporting cannabinoids (mostly dronabinol and nabilone) over placebo and against older antiemetics like prochlorperazine for CINV Strong evidence ^[1]. The 2017 National Academies report reached the same conclusion: "conclusive evidence" that oral cannabinoids are effective antiemetics in CINV Strong evidence ^[2]. A Cochrane review of cannabis-based medicines for CINV in adults also found benefit, though it noted that side effects (dizziness, dysphoria, sedation) often limit use Strong evidence ^[4].

Mechanism. CB1 receptors in the dorsal vagal complex inhibit the emetic reflex. CBD also reduces nausea in animal models at low doses through indirect 5-HT1A activation, though human data are sparse Weak / limited ^[5].

Practical reality. Modern 5-HT3 antagonists (ondansetron) combined with NK1 antagonists (aprepitant) and dexamethasone are first-line for CINV and work very well. Cannabinoids are typically used when those fail or as adjuncts, not as first-line agents ^[3].

What Might Work

HIV/AIDS-associated nausea and wasting. Dronabinol was originally approved for AIDS-related anorexia, and there is fair evidence it improves appetite and reduces associated nausea Weak / limited ^[2]. The HIV treatment landscape has changed so dramatically that this indication is rarely used today.

Postoperative nausea and vomiting (PONV). Small trials of nabilone and dronabinol for PONV have produced mixed results — some showing benefit, some showing no effect or even increased nausea Weak / limited ^[6]. Not recommended as standard care.

Functional dyspepsia, gastroparesis, cyclic vomiting syndrome (non-cannabinoid). Patients frequently report relief with cannabis Anecdote. Controlled trials are minimal. Given that cannabis itself can cause cyclic vomiting in heavy users, caution is warranted.

General/unspecified nausea. Many medical cannabis patients list nausea as a qualifying reason and report benefit. Self-report studies (e.g., from the Releaf app) show meaningful symptom reduction within an hour of inhaled cannabis Weak / limited ^[7]. These are uncontrolled and subject to expectancy effects.

What Probably Doesn't Work (Or We Have No Good Reason to Believe It Does)

Morning sickness (nausea and vomiting of pregnancy). There are no randomized trials supporting cannabis for pregnancy-related nausea. Despite increasing use for this purpose, major obstetric bodies including ACOG recommend against cannabis use in pregnancy because of evidence linking prenatal exposure to lower birth weight and neurodevelopmental concerns Strong evidence ^[8]. Whatever short-term symptom relief patients experience has not been weighed against fetal risk in any controlled study.

Motion sickness. No quality evidence. Anecdotal reports are split — some users say it helps, others say it makes them more nauseated No data.

Hangover nausea. No controlled data No data.

CBD alone for nausea in humans. Despite preclinical promise, human trials of isolated CBD as an antiemetic are essentially absent No data. Claims that CBD oil treats nausea are not backed by clinical evidence.

What We Don't Know

• The optimal dose, route, and chemotype of whole-plant cannabis for nausea. Most trial data come from oral THC, not inhaled flower.
• Whether specific terpenes (e.g., limonene, caryophyllene) contribute meaningfully to antiemetic effects in humans. This is widely claimed but not demonstrated in controlled studies Anecdote.
• Whether CBD or CBD:THC combinations outperform THC alone for nausea.
• Long-term comparative effectiveness vs. modern antiemetics.
• Why some chronic users develop cannabinoid hyperemesis syndrome and others don't.

Comparison With Standard Treatments

For CINV, the modern standard of care is a combination regimen:

• 5-HT3 antagonists (ondansetron, granisetron, palonosetron) — first-line, well-tolerated, very effective.
• NK1 antagonists (aprepitant, fosaprepitant) — added for highly emetogenic chemo.
• Corticosteroids (dexamethasone) — used in combination.
• Olanzapine — increasingly used as add-on; strong evidence in breakthrough nausea.

In head-to-head trials from the 1980s and 1990s, oral THC and nabilone outperformed older agents like prochlorperazine, but those comparisons predate the 5-HT3 era ^[1][3]. Cannabinoids today are positioned as second- or third-line or as adjuncts for breakthrough symptoms, not as replacements for ondansetron-based regimens ^[3]. For non-chemotherapy nausea, standard antiemetics (ondansetron, metoclopramide, promethazine, antihistamines, ginger) have much better evidence than cannabis.

Risks

• Cannabinoid hyperemesis syndrome (CHS). Paradoxical, severe, recurrent vomiting in chronic heavy cannabis users, often relieved temporarily by hot showers. The only reliable treatment is cannabis cessation Strong evidence ^[9]. If you use cannabis daily and develop new cycles of intractable vomiting, suspect CHS.
• Acute side effects of THC: dizziness, dysphoria, anxiety, sedation, tachycardia, impaired cognition. These are common enough in CINV trials that some patients stop the drug ^[1][4].
• Pregnancy: see above. Avoid.
• Drug interactions: THC and CBD are metabolized by CYP3A4 and CYP2C9/2C19; CBD inhibits several CYP enzymes and can raise levels of other drugs (e.g., clobazam, warfarin) Strong evidence ^[10].
• Tolerance and dependence: regular use leads to tolerance to antiemetic effects and to cannabis use disorder in roughly 1 in 10 users overall, higher in daily users.
• Smoke exposure: if cancer or chemo-related, smoked cannabis carries pulmonary risks; oral or vaporized forms are usually preferred in this population.

Sources

How this page was made

Related

• Cannabis Use Disorder — A real DSM-5 diagnosis affecting roughly 1 in 5 regular users, with modest but growing evi...